Q-linea launches IPO roadshow with cornerstones
The final two weeks of bookbuilding for the Skr632m (€61m) listing of Q-linea, the Swedish medical technology company, have begun on a positive note, after the firm announced that it had secured cornerstone interest for over 10% of the transaction.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: